Baidu
map

我国自主研发“骨科机器人”在成大附院上岗

2016-05-26 佚名 成都商报

这台骨科机器人名叫“天机”,由包括成都大学在内的多家高校和单位参与系统研发。 5月24日,“骨科机器人”在成都大学附属医院辅助医生进行手术。 病人躺在手术床上,X光片准确定位手术路径,骨科机器人切开一个1厘米长的小切口,利用机械臂的精确运动创造导针置入路径,最后由医生准确置入空心钉,一台骨盆骨折手术完成……5月24日,成都首个骨科机器人顺利完成一场手术,这是成都大学附属医院动用成都市首个

这台骨科机器人名叫“天机”,由包括成都大学在内的多家高校和单位参与系统研发。

5月24日,“骨科机器人”在成都大学附属医院辅助医生进行手术。

病人躺在手术床上,X光片准确定位手术路径,骨科机器人切开一个1厘米长的小切口,利用机械臂的精确运动创造导针置入路径,最后由医生准确置入空心钉,一台骨盆骨折手术完成……5月24日,成都首个骨科机器人顺利完成一场手术,这是成都大学附属医院动用成都市首个骨科机器人,进行的第三例手术。

这台骨科机器人名叫“天机”,由包括成都大学在内的多家高校和单位参与系统研发。由于切口小,手术快,出血少,相比于普通手术,骨科机器人动手术费用更为便宜。“以今天这台手术为例,如果进行普通手术,花费在5万元左右,而动用骨科机器人,整个手术费用才一万多。”

水平如何?目前属世界领先

据领衔骨科机器人研发的李开南教授介绍,目前骨科机器人为患者提供骨科手术治疗服务,主要运用于髓内钉远端锁钉定位、髋部骨折、骨盆骨折、脊柱椎弓根螺钉定位置钉等,骨科机器人还处在不断完善和研发当中。“目前它的主要价值体现在空心钉内固定手术方面,具有广阔的运用前景。”

据悉,成都市首次引进“骨科机器人”开展手术后,有望在各地医院进行推广。李开南教授表示,目前国际上比较成熟的达芬奇医用机器人主要用于腹腔手术,美国一款医用机器人主要进行脊柱固定,骨科机器人在骨科手术方面的表现在世界都处于领先水平,目前已经申请了多项国家专利。

成都参与研发 最大困难在精准定位

这款机器人由包括成都大学在内的多家高校和单位参与系统研发,李开南教授是机器人的主要研发者之一。从最初设想到最后完成研发,总共花费四年时间。

骨科机器人的研发也并非一帆风顺,李开南教授对记者说,研发期间也遇到过很多困难,他认为最大的困难在精准定位上。之前骨科机器人都是在骨骼模型上进行操作和实验,但是用于临床上,精准度不能有偏差,要把误差控制在1毫米以内。但骨折之后就会和正常的骨头不一样,为了克服精准度的问题,总共花了3、4年的时间来摸索和克服。目前,该骨科机器人的更多功能,还处于继续完善当中。

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (5)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=192103, encodeId=50f2192103c5, content=研发井喷期即将到来, beContent=null, objectType=article, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/04/24/1c2dbd6706e64df33befd6663f1d6b37.jpg, createdBy=94f61661779, createdName=lyh994, createdTime=Sun Apr 30 09:35:37 CST 2017, time=2017-04-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1672154, encodeId=faff16e21543b, content=<a href='/topic/show?id=177c85966dc' target=_blank style='color:#2F92EE;'>#自主研发#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=85966, encryptionId=177c85966dc, topicName=自主研发)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6d2c26890289, createdName=xlwang2700, createdTime=Tue Sep 27 07:26:00 CST 2016, time=2016-09-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1299922, encodeId=254c1299922ad, content=<a href='/topic/show?id=ed5ee332423' target=_blank style='color:#2F92EE;'>#研发#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=73324, encryptionId=ed5ee332423, topicName=研发)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=aea0290, createdName=lqvr, createdTime=Sat May 28 10:26:00 CST 2016, time=2016-05-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1321884, encodeId=e384132188490, content=<a href='/topic/show?id=890c611854e' target=_blank style='color:#2F92EE;'>#机器人#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=61185, encryptionId=890c611854e, topicName=机器人)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d139492, createdName=xue8602, createdTime=Sat May 28 10:26:00 CST 2016, time=2016-05-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1582947, encodeId=fe96158294ebb, content=<a href='/topic/show?id=f6e1611840d' target=_blank style='color:#2F92EE;'>#机器#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=61184, encryptionId=f6e1611840d, topicName=机器)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=13dc16973127, createdName=ms6279672939590805, createdTime=Sat May 28 10:26:00 CST 2016, time=2016-05-28, status=1, ipAttribution=)]
    2017-04-30 lyh994

    研发井喷期即将到来

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=192103, encodeId=50f2192103c5, content=研发井喷期即将到来, beContent=null, objectType=article, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/04/24/1c2dbd6706e64df33befd6663f1d6b37.jpg, createdBy=94f61661779, createdName=lyh994, createdTime=Sun Apr 30 09:35:37 CST 2017, time=2017-04-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1672154, encodeId=faff16e21543b, content=<a href='/topic/show?id=177c85966dc' target=_blank style='color:#2F92EE;'>#自主研发#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=85966, encryptionId=177c85966dc, topicName=自主研发)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6d2c26890289, createdName=xlwang2700, createdTime=Tue Sep 27 07:26:00 CST 2016, time=2016-09-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1299922, encodeId=254c1299922ad, content=<a href='/topic/show?id=ed5ee332423' target=_blank style='color:#2F92EE;'>#研发#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=73324, encryptionId=ed5ee332423, topicName=研发)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=aea0290, createdName=lqvr, createdTime=Sat May 28 10:26:00 CST 2016, time=2016-05-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1321884, encodeId=e384132188490, content=<a href='/topic/show?id=890c611854e' target=_blank style='color:#2F92EE;'>#机器人#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=61185, encryptionId=890c611854e, topicName=机器人)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d139492, createdName=xue8602, createdTime=Sat May 28 10:26:00 CST 2016, time=2016-05-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1582947, encodeId=fe96158294ebb, content=<a href='/topic/show?id=f6e1611840d' target=_blank style='color:#2F92EE;'>#机器#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=61184, encryptionId=f6e1611840d, topicName=机器)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=13dc16973127, createdName=ms6279672939590805, createdTime=Sat May 28 10:26:00 CST 2016, time=2016-05-28, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=192103, encodeId=50f2192103c5, content=研发井喷期即将到来, beContent=null, objectType=article, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/04/24/1c2dbd6706e64df33befd6663f1d6b37.jpg, createdBy=94f61661779, createdName=lyh994, createdTime=Sun Apr 30 09:35:37 CST 2017, time=2017-04-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1672154, encodeId=faff16e21543b, content=<a href='/topic/show?id=177c85966dc' target=_blank style='color:#2F92EE;'>#自主研发#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=85966, encryptionId=177c85966dc, topicName=自主研发)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6d2c26890289, createdName=xlwang2700, createdTime=Tue Sep 27 07:26:00 CST 2016, time=2016-09-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1299922, encodeId=254c1299922ad, content=<a href='/topic/show?id=ed5ee332423' target=_blank style='color:#2F92EE;'>#研发#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=73324, encryptionId=ed5ee332423, topicName=研发)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=aea0290, createdName=lqvr, createdTime=Sat May 28 10:26:00 CST 2016, time=2016-05-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1321884, encodeId=e384132188490, content=<a href='/topic/show?id=890c611854e' target=_blank style='color:#2F92EE;'>#机器人#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=61185, encryptionId=890c611854e, topicName=机器人)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d139492, createdName=xue8602, createdTime=Sat May 28 10:26:00 CST 2016, time=2016-05-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1582947, encodeId=fe96158294ebb, content=<a href='/topic/show?id=f6e1611840d' target=_blank style='color:#2F92EE;'>#机器#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=61184, encryptionId=f6e1611840d, topicName=机器)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=13dc16973127, createdName=ms6279672939590805, createdTime=Sat May 28 10:26:00 CST 2016, time=2016-05-28, status=1, ipAttribution=)]
    2016-05-28 lqvr
  4. [GetPortalCommentsPageByObjectIdResponse(id=192103, encodeId=50f2192103c5, content=研发井喷期即将到来, beContent=null, objectType=article, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/04/24/1c2dbd6706e64df33befd6663f1d6b37.jpg, createdBy=94f61661779, createdName=lyh994, createdTime=Sun Apr 30 09:35:37 CST 2017, time=2017-04-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1672154, encodeId=faff16e21543b, content=<a href='/topic/show?id=177c85966dc' target=_blank style='color:#2F92EE;'>#自主研发#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=85966, encryptionId=177c85966dc, topicName=自主研发)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6d2c26890289, createdName=xlwang2700, createdTime=Tue Sep 27 07:26:00 CST 2016, time=2016-09-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1299922, encodeId=254c1299922ad, content=<a href='/topic/show?id=ed5ee332423' target=_blank style='color:#2F92EE;'>#研发#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=73324, encryptionId=ed5ee332423, topicName=研发)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=aea0290, createdName=lqvr, createdTime=Sat May 28 10:26:00 CST 2016, time=2016-05-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1321884, encodeId=e384132188490, content=<a href='/topic/show?id=890c611854e' target=_blank style='color:#2F92EE;'>#机器人#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=61185, encryptionId=890c611854e, topicName=机器人)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d139492, createdName=xue8602, createdTime=Sat May 28 10:26:00 CST 2016, time=2016-05-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1582947, encodeId=fe96158294ebb, content=<a href='/topic/show?id=f6e1611840d' target=_blank style='color:#2F92EE;'>#机器#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=61184, encryptionId=f6e1611840d, topicName=机器)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=13dc16973127, createdName=ms6279672939590805, createdTime=Sat May 28 10:26:00 CST 2016, time=2016-05-28, status=1, ipAttribution=)]
    2016-05-28 xue8602
  5. [GetPortalCommentsPageByObjectIdResponse(id=192103, encodeId=50f2192103c5, content=研发井喷期即将到来, beContent=null, objectType=article, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/04/24/1c2dbd6706e64df33befd6663f1d6b37.jpg, createdBy=94f61661779, createdName=lyh994, createdTime=Sun Apr 30 09:35:37 CST 2017, time=2017-04-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1672154, encodeId=faff16e21543b, content=<a href='/topic/show?id=177c85966dc' target=_blank style='color:#2F92EE;'>#自主研发#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=85966, encryptionId=177c85966dc, topicName=自主研发)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6d2c26890289, createdName=xlwang2700, createdTime=Tue Sep 27 07:26:00 CST 2016, time=2016-09-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1299922, encodeId=254c1299922ad, content=<a href='/topic/show?id=ed5ee332423' target=_blank style='color:#2F92EE;'>#研发#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=73324, encryptionId=ed5ee332423, topicName=研发)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=aea0290, createdName=lqvr, createdTime=Sat May 28 10:26:00 CST 2016, time=2016-05-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1321884, encodeId=e384132188490, content=<a href='/topic/show?id=890c611854e' target=_blank style='color:#2F92EE;'>#机器人#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=61185, encryptionId=890c611854e, topicName=机器人)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d139492, createdName=xue8602, createdTime=Sat May 28 10:26:00 CST 2016, time=2016-05-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1582947, encodeId=fe96158294ebb, content=<a href='/topic/show?id=f6e1611840d' target=_blank style='color:#2F92EE;'>#机器#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=61184, encryptionId=f6e1611840d, topicName=机器)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=13dc16973127, createdName=ms6279672939590805, createdTime=Sat May 28 10:26:00 CST 2016, time=2016-05-28, status=1, ipAttribution=)]

相关资讯

Stroke:我国卒中领域SMART项目是否可行?

近日,北京协和医院崔丽英教授等公布的SMART (卒中管理与临床研究培训)项目最新结果表明,SMART项目在我国缺血性卒中二级预防中可行,但该项目在提高患者的治疗依从性和改善1年临床结局等方面的作用有限。研究者指出,我国人群中缺血性卒中发生率较高,而患者对二级预防措施的依从性较差。SMART项目可提高我国缺血性卒中患者对他汀治疗的依从性,该研究为调整卒中管理方案提供了有用的信息,从而为进一步改善卒

我国推出重症脑损伤患者镇痛镇静专家共识

镇痛镇静药物对重症脑损伤病人意识评估有何影响?镇痛镇静治疗在缺乏高级别循证医学证据时,尤其是对远期神经系统转归又有何影响?在低温治疗中如何选择应用镇痛镇静药物?这些以往临床有争议的话题而今有了专业性的指导方案。日前,中国医师协会神经外科医师分会神经重症专家委员会正式发布了“重症脑损伤患者镇痛镇静专家共识”(以下简称共识),以其规范神经重症医学的临床医疗实践,这对提高我国重症脑损伤病人的救治水平具有

Lancet:中国结核病控制成效

2014年3月18日,国际顶尖医学杂志《柳叶刀,Lancet》发表了中国疾病预防控制中心专家撰写的题为《1990-2010年中国人群肺结核患病率:全国调查数据的纵向分析(Tuberculosis Prevalence in China, 1990–2010;a Longitudinal Analysis of National Survey Data)》的文章。文章通过分析三次全国结核病患病率的调

178项研究、近300万人资料的汇总分析显示:我国高血压控制率15年无改善

中国医学科学院阜外医院蔡军等汇总分析了全国30个省份的高血压流行病学数据发现,过去十几年,我国高血压的患病率没有显著变化,徘徊在30%左右。治疗率有所提高,但是控制率却未有相应的提高,仍较低。 当前我国高血压的总患病率为28.9%,高血压治疗率和控制率分别为35.3%和13.4%。 图1 我国高血压患病率、治疗率和控制率变化趋势 研究数据表明,我国高血压流行存在明显的区域

产房故事观察类真人秀开播

 一部真实、全方位展现分娩过程中产妇、产妇家庭及医护人员三方微妙互动的12集大型观察类真人秀《来吧,孩子》5月9日起已在深圳卫视开播。 据悉,节目从筹划到开拍历时近2年。期间,深圳卫视节目组带领中外团队在全国范围内寻找适合的拍摄点,最终选定了有着130年悠久历史、良好社会声誉及口碑的“上海红房子医院”(复旦大学附属妇产科医院)。在保证患者知情同意、确保医疗安全的基础上,经充分准备,

詹思延:我国55岁以上人群每百人中约有一位VD患者

近日由北京大学公共卫生学院、北京大学精神卫生研究所、卫生部精神卫生重点实验室联合完成的一项研究显示,中国社区55岁以上人群血管性痴呆(VD)的患病率为0.8%;1980年至今患病率呈缓慢上升趋势,并有明显的南北和城乡差异,年龄、性别、教育程度等都会对该病的发病率产生影响。此研究为政府相关部门早期干预以及临床防治提供了最基础的科学数据。 随着人均寿命的延长,痴呆成为一项备受关注的公共卫生问

Baidu
map
Baidu
map
Baidu
map